3 minutes ago, 6:52am (ET) 04/17/2013 DatamonitorUroplasty, Inc., a medical device company, has appointed Robert Kill as its interim CEO. David Kaysen has tendered his resignation as president, CEO and a member of the board of directors.James Stauner, ...
[Published Zecco - Apr 17 2013]